Investigation of leptomeningeal enhancement in MS: A postcontrast FLAIR MRI study

Neurology

Volumn 84, Issue 8, 2015, Pages 770-775

  Eisele, Philipp ^a   Griebe, Martin ^a   Szabo, Kristina ^a   Wolf, Marc E ^a   Alonso, Angelika ^a   Engelhardt, Britta ^b   Hennerici, Michael G ^a   Gass, Achim ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; NATALIZUMAB; CONTRAST MEDIUM;

ADULT; ANTERIOR CEREBRAL ARTERY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLUID ATTENUATED INVERSION RECOVERY MAGNETIC RESONANCE IMAGING; HOSPITAL ADMISSION; HUMAN; LEPTOMENINX; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; MULTIPLE SCLEROSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR INFERIOR CEREBELLAR ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEMPORAL LOBE; DIAGNOSTIC USE; MENINX; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADULT; BLOOD-BRAIN BARRIER; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGES; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES;

EID: 84923668974     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001286     Document Type: Article

References (32)

1. Guttmann CR, Ahn SS, Hsu L, Kikinis R, Jolesz FA. The evolution of multiple sclerosis lesions on serial MR. AJNR Am J Neuroradiol 1995;16:1481-1491
2. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990;113:1477-1489
3. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301
4. Barkhof F, Valk J, Hommes OR, Scheltens P. Meningeal Gd-DTPA enhancement in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:397-400
5. Demaerel P, Robberecht W, Casteels I, et al. Focal leptomeningeal MR enhancement along the chiasm as a presenting sign of multiple sclerosis. J Comput Assist Tomogr 1995;19:297-298
6. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257-263
7. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56:468-477
8. Kidwell CS, Burgess R, Menon R, Warach S, Latour LL. Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption. Neurology 2011;77:1725-1728
9. Hamilton BE, Nesbit GM. Delayed CSF enhancement in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:456-457
10. Weier K, Fluri F, Kos S, Gass A. Postcontrast FLAIR MRI demonstrates blood-brain barrier dysfunction in PRES. Neurology 2009;72:760-762
11. Naul LG, Finkenstaedt M. Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor. AJNR Am J Neuroradiol 1997;18:1709-1711
12. Salvarani C, Brown RD Jr, Calamia KT, et al. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum 2008;58:595-603
13. Wengert O, Rothenfusser-Korber E, Vollrath B, et al. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity. J Neurol Sci 2013; 335:124-130
14. Hsu HL, Chen CJ. Extensive cerebrospinal fluid enhancement following gadolinium chelate administration: possible pathogenesis. Acta Radiol 2005;46:523-527
15. Brant-Zawadzki M, Atkinson D, Detrick M, Bradley WG, Scidmore G. Fluid-attenuated inversion recovery (FLAIR) for assessment of cerebral infarction: initial clinical experience in 50 patients. Stroke 1996;27:1187-1191
16. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25
17. Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008;67:1113-1121
18. Bar T. The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol 1980;59:I-VI, 1-62
19. Allt G, Lawrenson JG. Is the pial microvessel a good model for blood-brain barrier studies? Brain Res Brain Res Rev 1997;24:67-76
20. Barkalow FJ, Goodman MJ, Gerritsen ME, Mayadas TN. Brain endothelium lack one of two pathways of P-selectinmediated neutrophil adhesion. Blood 1996;88:4585-4593
21. Olincy A, Young DA, Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 1997;42: 1-5
22. Doring A, Wild M, Vestweber D, Deutsch U, Engelhardt B. E-and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J Immunol 2007;179: 8470-8479
23. Engelhardt B, Coisne C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 2011;8:4
24. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011;134:2755-2771
25. Calabrese M, Filippi M, Rovaris M, et al. Morphology and evolution of cortical lesions in multiple sclerosis: a longitudinal MRI study. Neuroimage 2008;42: 1324-1328
26. van Horssen J, Brink BP, de Vries HE, van der Valk P, Bo L. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007;66:321-328
27. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9: 323-331
28. Brink BP, Veerhuis R, Breij EC, van der Valk P, Dijkstra CD, Bo L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64:147-155
29. Kooi EJ, Geurts JJ, van Horssen J, Bo L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol 2009;68:1021-1028
30. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26
31. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
32. Takano A, Piehl F, Hillert J, et al. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. EJNMMI Res 2013;3:30.